HAPPENING NOW
The headlines, minus the noise. Updated in real time. Beta
Scientists cautiously suggest GLP-1s are safe to use around pregnancy
Scientists from the University of St Andrews conducted a study on GLP-1 receptor agonists, including Ozempic, and pregnancy. The study, published in the American Journal of Obstetrics and Gynaecology, found no increased risk of major birth defects among over 49,000 pregnancies…
AI Summary Powered by HappeningNow
Scientists from the University of St Andrews conducted a study on GLP-1 receptor agonists, including Ozempic, and pregnancy. The study, published in the American Journal of Obstetrics and Gynaecology, found no increased risk of major birth defects among over 49,000 pregnancies exposed to these medications. The review spanned 20 years.
Read full article →AI summaries can be wrong sometimes—always verify important details using the source link below.